Poland· PL-100105196

Loratan

A loratadine product containing loratadinum, registered in Poland by Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.. The same ATC class is registered in 18 of our 19 countries.

ATC R06AX13

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLoratanATCR06AX13REGISTER NO.PL-100105196PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Loratadine is registered in 18 of 19 countries.

Countries holding a registration under ATC R06AX13 (loratadine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 10 of them publish a price we can compare per daily dose

Loratadine · ATC R06AX13

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of loratadine costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.18 in France to $0.57 in Switzerland — a ×3.2 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Loratadine · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.57
  • IT Italy$0.21
  • FR France$0.18
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Loratadinum
Manufacturer
Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
Country
Poland (PL)
ATC code
R06AX13
ATC class
Loratadine
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

1 priced
  • gtin
    05909990909049
    30 szt.
    PLN 17.06
  • gtin
    05909990909018
  • gtin
    05909990909025
  • gtin
    05909990909032

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

539 interactions on record for loratadine.

Graded by severity as the source publishes them — 74 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Loratadine · interactions on record

539 records

  • 74 moderate
  • 12 minor
  • 453 info

Most severe, free to view

  • TroglitazoneA10BG01moderate
  • Glycerol phenylbutyrateA16AX09moderate
  • LonafarnibA16AX20moderate
  • FostamatinibB02BX09moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Loratadine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All loratadine products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Allernon, Clarityn
  • Belgium · Claritine, Loratadine Eg
  • Bulgaria · Кларитин, Лорано
  • Cyprus · Clarityne, Lorytec
  • Czechia · Claritine, Flonidan
  • Germany · Lora, Lorano Akut
  • Denmark · Clarityn, Loratadine Ratiopharm
  • Estonia · Claritine, Loratadine Accord
  • Spain · Civerán, Clarityne
  • Finland · Loratadin Ratiopharm, Loratadine Accord
  • France · Clarityne, Humex Allergie
  • United Kingdom (Northern Ireland) · Allergy Relief, Asda One-A-Day Hayfever And Allergy
  • Greece · Bollinol, Bollinol®
  • Croatia · Belodin, Belodin A
  • Hungary · Claritine, Erolin
  • Ireland · Clareeze Allergy, Clarityn
  • Iceland · Clarityn, Lóritín
  • Italy · Clarityn, Fristamin
  • Lithuania · Claritine, Lomilan
  • Latvia · Claritine, Loracip
  • Malta · Clarityn, Horestyl
  • Netherlands · Allerfre, Claritine
  • Norway · Clarityn, Loratadin Hexal
  • Portugal · Claritine, Loratadina 1apharma
  • Romania · Alerityn, Claritine
  • Sweden · Clarityn, Loratadin Abece
  • Slovenia · Claritine, Claritine S
  • Slovakia · Claritine, Erolin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/45401c57-f4a8-4d36-9efb-3001d5e77b6f
GET /v1/drugs/45401c57-f4a8-4d36-9efb-3001d5e77b6f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki miękkie",
  "source": "urpl",
  "strength": "10 mg",
  "packaging": "05909990909018 ¦ OTC ¦ Skasowane ¦ 18182\n7 kaps.\n05909990909025 ¦ OTC ¦ Skasowane ¦ 18183\n10 kaps.\n05909990909032 ¦ Rp ¦ 18184\n15 kaps.\n05909990909049 ¦ Rp ¦ 18185\n30 kaps.",
  "substance": "Loratadinum 10 mg",
  "common_name": "Loratadinum",
  "pl_product_id": "100105196",
  "pozwolenie_nr": "09090",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about loratadine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.